DC Field | Value | Language |
dc.contributor.author | Shulginova, A. A. | - |
dc.contributor.author | Konoplya, A. I. | - |
dc.contributor.author | Bystrova, N. A. | - |
dc.date.accessioned | 2022-04-27T16:04:04Z | - |
dc.date.available | 2022-04-27T16:04:04Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Shulginova, A.A. Disorders of the immune status in patients with chronic cerebral ischemia; differentiated pharmacological correction / A.A. Shulginova, A.I. Konoplya, N.A. Bystrova // Research result: pharmacology and clinical pharmacology. - 2018. - Vol. 4, № 2.- P. 105-123. - Doi: 10.3897/rrpharmacology.4.28304. | ru |
dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46420 | - |
dc.description.abstract | The objective of the study is to establish the immune disorder patterns in patients with CCI I-II associated with arterial hypertension and to develop differentiated pharmacological methods for their correction | ru |
dc.language.iso | en | ru |
dc.subject | medicine | ru |
dc.subject | pharmacology | ru |
dc.subject | immunocorrectors | ru |
dc.subject | chronic cerebral ischemia | ru |
dc.subject | neurological | ru |
dc.subject | cognitive | ru |
dc.subject | immune disorders | ru |
dc.subject | immunomodulating correction | ru |
dc.title | Disorders of the immune status in patients with chronic cerebral ischemia; differentiated pharmacological correction | ru |
dc.type | Article | ru |
Appears in Collections: | Vol. 4, № 2
|